site sponsored by
Tag Archive | "lorcaserin"
Tags: arena-pharma, being-published, england-journal, first-developer, health, helping-fuel, lorcaserin, nervous-system, orphan drug status, our-development, panelist, qnexa, weight loss
Arena shares surge on new round of promising lorcaserin data
Posted on 15 July 2010
Posted in Top NewsComments (0)
Tags: arena pharmaceuticals, cover-the-rest, development, eisai, lorcaserin, marketing, medical, numbers
Arena lands $1.3B weight drug pact with Eisai
Posted on 01 July 2010
Posted in Top NewsComments (0)
Tags: arena pharmaceuticals, clinical-trials, contract-sales, drug, its-antibody, its-partnership, lorcaserin, obesity, pharmaceuticals, results-release, sales, securities, terms-were, will-certainly
Arena will launch lorcaserin with or without partner
Posted on 12 March 2010
Posted in Top NewsComments (0)
Tags: arena pharmaceuticals, biotech, important, lorcaserin, most-important, patients, potential
Arena Pharma gains $100M from Deerfield
Posted on 17 June 2009
Posted in Top NewsComments (0)
Tags: biotech, china, condition, cystic-fibrosis, development, europe, lorcaserin, opportunity, patients, pharnext, sales, the-therapeutic, united, united-states
Ipsen, Pharnext ink $126M deal
Posted on 17 June 2009
Posted in Top NewsComments (0)
Tags: arena-pharma, clinical trial results, lorcaserin, lost-at-least, News, obesity, pharmaceuticals, placebo, press-release, treatment
Arena shares shoot up on positive obesity data
Posted on 09 June 2009
Posted in Top NewsComments (0)
Tags: booming-market, chinese, developing-new, emerging-markets, investment, lorcaserin, obesity, pharmaceuticals, treatment, vaccine-doses
Glaxo makes $34M leap into Chinese vaccine market
Posted on 09 June 2009
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Let’s Just Spread This Deal Out All Over the Paper, Why Don’t We?
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
